eXoZymes (EXOZ) vs Genenta Science S.p.A. (SAEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
eXoZymes is the larger company by market cap ($27.4 million vs $24.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | SAEN |
|---|---|---|
| Share price | $2.91 | $0.5074 |
| Market cap | $27.42M | $24.47M |
| 1-day change | -14.05% | -9.39% |
| YTD return | -73.35% | — |
| 1-year return | -81.84% | — |
| EPS (TTM) | $-1.16 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-9.16M | — |
| 52-week high | $16.16 | $2.58 |
| 52-week low | $2.81 | $0.50 |
| Distance from 52-week high | -82.02% | -80.33% |
| Analyst consensus | strong_buy | — |
| Average volume | 10.14K | 85.01K |
| Shares outstanding | 9.44M | 48.22M |
| Employees | 32 | 9 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About eXoZymes
EXOZ stock →eXoZymes, Inc. operates as a development stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 32 employees
About Genenta Science S.p.A.
SAEN stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees
EXOZ vs SAEN FAQ
Which is bigger, eXoZymes or Genenta Science S.p.A.?
eXoZymes (EXOZ) is larger, with a market capitalization of $27.42M compared with $24.47M for Genenta Science S.p.A. (SAEN).
Are eXoZymes and Genenta Science S.p.A. in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.